Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BBR 3464 in Inoperable Locally Advanced or Metastatic Pancreatic Adenocarcinoma
NCT00024362Phase 2Unknown
- Sponsor
- Theradex Oncology
- Start
- May 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of triplatin in pancreatic adenocarcinoma (PDAC), sponsored by Theradex Oncology. Status: unknown.
02
Drugs
triplatin
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on NCT00024362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00024362.